Filtration In Biopharmaceutical Development & Manufacturing
Pharmaceutical formulations, drug products, therapies, vaccines and the processes by which they are made are becoming increasingly diverse. Whether used for clarification or sterilization of final material, filtration remains an essential part of them.
In this presentation, Tom Watson talks about Pall’s range of filters including carbon removal filters, sterilizing grade filters (liquid and air/gas applications) and pre-filters for different types of drugs and manufacturing processes.
You will also understand how Pall is continuing to innovate in the field of prefiltration and sterilizing grade filtration in response to evolving regulatory standards and changes in drug classes.
Participants will learn about:
- How to select a right filter for your product and process.
- What’s new in the pre-filtration and sterilizing grade filtration.
- Integrity testing of hydrophilic and hydrophobic filters.
Speaker
Tom Watson
Global Product Manager, Sterilizing Grade Filters
Pall
Tom joined Pall in 2003, having graduated from the University of Sheffield, UK with a degree in Biotechnology and Microbiology. Following several years as an Account Manager, in 2010 he joined the Global Product Marketing first as Global Product Manager, Sterilizing-grade Filters and is now marketing group leader for Sterilizing grade filters, test instruments and systems.
Filtration In Biopharmaceutical Development & Manufacturing
Prepare for a Successful Validation of Liposome-Based Drugs
Download this guide to get recommendations for applying QbD principles for sterility assurance during aseptic processing
Biotech | Pall Corporation webinar series
Why the introduction of X-ray sterilization technology is a critical change for single-use industry, and how gamma and X-ray irradiation compare
The market demand for gamma irradiation, the current primary method for the sterilization in SUT, will soon significantly exceed supply, creating an urgent need for alternatives.
Join Christelle Marcoux from GSK Vaccines (BioPhorum workstream member on alternatives to gamma sterilization) and James Hathcock, PhD of Pall Corporation (Bio-Process Systems Alliance X-Ray Committee Co-Chair) as they discuss the introduction of X-ray sterilization technology.
You will learn more about:
- Why this is a critical change for industry and the responsibilities of each stakeholder
- Key questions to address for biomanufacturers
- How gamma and X-ray irradiation compare
- What testing has been completed and key milestones for readiness for industry
- An example of how to qualify a SUS sterilized with X-ray irradiation